arabinofuranosyluracil has been researched along with Granulocytic Leukemia, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chun, KS; Kang, JH; Kim, KI; Lee, TS; Lee, YJ; Park, JJ; Park, YS; Son, JJ; Song, IH | 1 |
| Akerman, S; Arlin, Z; Baskind, P; Budman, DR; DeAngelis, L; Feldman, EJ; Kreis, W; Lesser, M | 1 |
2 other study(ies) available for arabinofuranosyluracil and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Comparison of cell-labeling methods with ¹²⁴I-FIAU and ⁶⁴Cu-PTSM for cell tracking using chronic myelogenous leukemia cells expressing HSV1-tk and firefly luciferase.
Topics: Animals; Arabinofuranosyluracil; Cell Tracking; Copper Radioisotopes; Female; Gene Transfer Techniques; Herpesvirus 1, Human; Humans; Iodine Radioisotopes; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Luciferases, Firefly; Mice; Mice, Inbred BALB C; Mice, Nude; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Thiosemicarbazones; Thymidine Kinase; Transplantation, Heterologous | 2012 |
Phenotypic analysis of 1-B-D-arabinofuranosylcytosine deamination in patients treated with high doses and correlation with response.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arabinofuranosyluracil; Cytarabine; Deamination; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Phenotype; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Serum Albumin, Bovine; Sex Factors | 1992 |